首页 > 最新文献

Acta Biomaterialia最新文献

英文 中文
Targeting injury-triggered grancalcin from senescent macrophages enhances aged bone healing 来自衰老巨噬细胞的靶向损伤触发的巨噬素促进衰老骨愈合。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-03-01 Epub Date: 2025-12-16 DOI: 10.1016/j.actbio.2025.12.031
Yangjiele Dong , Xin Shen , Qianwei Zhuang , Shenghao Jin , Zesheng Song , Ziji Ling , Hongbing Jiang
Age-related decline in bone regenerative capacity poses a significant challenge for craniofacial skeleton repair in elderly patients. Grancalcin (GCA), a calcium-binding protein secreted by myeloid cells, has been identified as a potential contributor to the process of skeletal aging. However, its specific role in age-related craniofacial bone regeneration remains poorly understood. Using a mouse model of tooth extraction socket healing, we show that GCA from bone marrow-derived macrophages (BMDMs) regulates both cellular senescence and osteogenic differentiation of bone marrow stromal cells (BMSCs) during bone regeneration in aged mice. Mechanistically, the injury-responsive transcription factors c-Jun and SPI1 act synergistically to drive Gca expression in senescent BMDMs, thereby impairing mitochondrial function and osteogenesis in BMSCs via the Plxnb2-Arg2 axis. Furthermore, we engineered a gelatin methacryloyl (GelMA) hydrogel for the sustained local delivery of a GCA-neutralizing antibody (GelMA–GCA-NAb). Local application of this hydrogel markedly enhanced jaw bone healing in aged mice. Our findings identify injury-induced GCA as a key mediator connecting immune senescence to deficient bone regeneration and propose local GCA neutralization via hydrogel as a promising immunotherapeutic strategy to improve bone healing in the elderly.

Statement of significance

Current conventional therapies for age-related bone healing face limitations in addressing aging-impaired biological processes, while hydrogels delivering targeted factors show significant promise by enabling precise modulation of the local microenvironment. This study reveals that c-Jun/SPI1-driven GCA from senescent macrophages promotes BMSCs senescence and impairs osteogenesis via Plxnb2-Arg2 in age-related jawbone injury. Importantly, local delivery of a GCA-neutralizing antibody via GelMA hydrogel accelerates healing, offering an emerging therapeutic strategy.
年龄相关性骨再生能力下降对老年患者颅面骨修复提出了重大挑战。钙蛋白(GCA)是一种由骨髓细胞分泌的钙结合蛋白,已被确定为骨骼衰老过程的潜在贡献者。然而,其在与年龄相关的颅面骨再生中的具体作用仍然知之甚少。通过拔牙窝愈合小鼠模型,我们发现来自骨髓源性巨噬细胞(bmdm)的GCA在老年小鼠骨再生过程中调节细胞衰老和骨髓基质细胞(BMSCs)的成骨分化。从机制上讲,损伤反应转录因子c-Jun和SPI1协同作用,驱动衰老BMSCs中Gca的表达,从而通过Plxnb2-Arg2轴损害BMSCs的线粒体功能和成骨。此外,我们设计了一种明胶甲基丙烯酰(GelMA)水凝胶,用于持续局部递送gca中和抗体(GelMA- gca - nab)。局部应用该水凝胶可显著促进老年小鼠颌骨愈合。我们的研究结果确定了损伤诱导的GCA是连接免疫衰老和骨再生缺陷的关键介质,并提出通过水凝胶局部中和GCA作为一种有前途的免疫治疗策略来改善老年人的骨愈合。意义声明:目前与年龄相关的骨愈合的常规疗法在解决衰老受损的生物过程方面面临局限性,而水凝胶通过精确调节局部微环境来传递靶向因子,显示出重大的前景。本研究表明,c-Jun/ spi1驱动的衰老巨噬细胞GCA通过Plxnb2-Arg2促进BMSCs衰老,并在年龄相关性颌骨损伤中损害成骨。重要的是,通过GelMA水凝胶局部递送gca中和抗体加速愈合,提供了一种新兴的治疗策略。
{"title":"Targeting injury-triggered grancalcin from senescent macrophages enhances aged bone healing","authors":"Yangjiele Dong ,&nbsp;Xin Shen ,&nbsp;Qianwei Zhuang ,&nbsp;Shenghao Jin ,&nbsp;Zesheng Song ,&nbsp;Ziji Ling ,&nbsp;Hongbing Jiang","doi":"10.1016/j.actbio.2025.12.031","DOIUrl":"10.1016/j.actbio.2025.12.031","url":null,"abstract":"<div><div>Age-related decline in bone regenerative capacity poses a significant challenge for craniofacial skeleton repair in elderly patients. Grancalcin (GCA), a calcium-binding protein secreted by myeloid cells, has been identified as a potential contributor to the process of skeletal aging. However, its specific role in age-related craniofacial bone regeneration remains poorly understood. Using a mouse model of tooth extraction socket healing, we show that GCA from bone marrow-derived macrophages (BMDMs) regulates both cellular senescence and osteogenic differentiation of bone marrow stromal cells (BMSCs) during bone regeneration in aged mice. Mechanistically, the injury-responsive transcription factors c-Jun and SPI1 act synergistically to drive <em>Gca</em> expression in senescent BMDMs, thereby impairing mitochondrial function and osteogenesis in BMSCs via the Plxnb2-Arg2 axis. Furthermore, we engineered a gelatin methacryloyl (GelMA) hydrogel for the sustained local delivery of a GCA-neutralizing antibody (GelMA–GCA-NAb). Local application of this hydrogel markedly enhanced jaw bone healing in aged mice. Our findings identify injury-induced GCA as a key mediator connecting immune senescence to deficient bone regeneration and propose local GCA neutralization via hydrogel as a promising immunotherapeutic strategy to improve bone healing in the elderly.</div></div><div><h3>Statement of significance</h3><div>Current conventional therapies for age-related bone healing face limitations in addressing aging-impaired biological processes, while hydrogels delivering targeted factors show significant promise by enabling precise modulation of the local microenvironment. This study reveals that c-Jun/SPI1-driven GCA from senescent macrophages promotes BMSCs senescence and impairs osteogenesis via Plxnb2-Arg2 in age-related jawbone injury. Importantly, local delivery of a GCA-neutralizing antibody via GelMA hydrogel accelerates healing, offering an emerging therapeutic strategy.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"212 ","pages":"Pages 562-578"},"PeriodicalIF":9.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biodegradable sodium citrate-treated hyaluronic acid microspheres for genicular artery embolization 可生物降解柠檬酸钠处理的透明质酸微球用于膝动脉栓塞。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-03-01 Epub Date: 2026-01-06 DOI: 10.1016/j.actbio.2026.01.003
Kierdra I. Dowling , Tesnime Hidjir , Lizhe Zhang , Bianca Di Carlo , Amid Shakeri , Ka Kit Cheung , Edmond W.K. Young , Milica Radisic , Mohammad Moeini , Sebastian Mafeld , Naomi Matsuura
Genicular artery embolization (GAE) using microparticulate embolic agents has recently been shown to improve pain and function in knee osteoarthritis (OA) patients. Despite encouraging outcomes, current clinical embolics are repurposed from non-GAE applications and remain suboptimal due to non-degradability or non-spherical shape, highlighting a need for biodegradable microspherical embolics specifically designed for GAE. Here, we engineered 1,4-butanediol diglycidyl ether (BDDE)-crosslinked hyaluronic acid (HA) microspheres with properties fine-tuned for GAE using a salt treatment approach, targeting a size range of ∼75–300 μm and degradation time of ∼48 h. Sodium citrate (Cit)-treated HA (HACit) microspheres with tunable properties were fabricated via emulsion crosslinking in the presence of varying Cit concentrations (0–20% w/v, named HACit-0 to HACit-20). >92% of microspheres measured between 75–300 µm. Treatment with 10% Cit (HACit-10) reduced the average microsphere size (from 195 ± 55 µm to 151 ± 53 µm), decreased the swelling ratio (from 24.3 ± 3.5 to 7.4 ± 0.1), and prolonged the in vitro degradation time (from 33 ± 3 h to 56 ± 4 h) compared to untreated microspheres (HACit-0). In a microfluidic occlusion test, HACit-10 microspheres exhibited enhanced strength to stably block microchannels, while HACit-0 microspheres failed to cause obstructions. NMR analysis verified complete Cit removal after microsphere washing, leaving FDA-approved BDDE-crosslinked HA as the sole embolic material. Cytotoxicity assessments using human umbilical vein endothelial cells (HUVECs) and human dermal fibroblasts (HDFs) demonstrated cytocompatibility of HACit-10 microspheres. Collectively, HACit-10 microspheres fulfilled the proposed design criteria, representing a promising embolic agent for GAE.

Statement of significance

Knee osteoarthritis (OA) is the most common joint disease, with pain being the most prominent symptom. Genicular artery embolization (GAE) provides an alternative option for a substantial subset (∼20%) of OA patients who fall into a treatment gap—those unresponsive to conservative treatments yet ineligible for total knee replacement. Hyaluronic acid (HA) microspheres are promising candidates for developing GAE-indicated embolics, as HA-based products are biocompatible, biodegradable, non-immunogenic, and FDA-approved for intra-articular injections, facilitating clinical translation. However, achieving an optimal balance of size, mechanical properties, and degradation time is challenging through crosslinker concentration adjustment alone. This study employs a recently developed salt treatment method to fabricate HA microspheres with suitable size, enhanced mechanical strength, and fine-tuned degradation kinetics, tailored for GAE.
使用微颗粒栓塞剂进行膝动脉栓塞(GAE)最近被证明可以改善膝关节骨关节炎(OA)患者的疼痛和功能。尽管取得了令人鼓舞的结果,但目前的临床栓子从非GAE应用中重新定位,并且由于不可降解或非球形,仍然不是最佳选择,这突出了对专门为GAE设计的可生物降解微球形栓子的需求。在这里,我们设计了1,4-丁二醇二甘油酯醚(BDDE)交联透明质酸(HA)微球,使用盐处理方法对其性能进行微调,目标尺寸范围为~ 75-300 μm,降解时间为~ 48小时。柠檬酸钠(Cit)处理的透明质酸(HACit)微球具有可调的性能,通过乳液交联在不同Cit浓度(0-20% w/v,命名为HACit-0至HACit-20)的存在下制备。超过92%的微球在75-300微米之间。与未处理的微球(HACit-0)相比,10% Cit处理(HACit-10)减少了平均微球尺寸(从195±55µm到151±53µm),降低了溶胀率(从24.3±3.5到7.4±0.1),延长了体外降解时间(从33±3 h到56±4 h)。在微流体阻塞测试中,HACit-10微球表现出增强的强度,可以稳定地阻塞微通道,而HACit-0微球则不能阻塞微通道。核磁共振分析证实微球洗涤后完全去除Cit,留下fda批准的bdde交联HA作为唯一的栓塞材料。使用人脐静脉内皮细胞(HUVECs)和人真皮成纤维细胞(HDFs)进行细胞毒性评估,结果表明HACit-10微球具有细胞相容性。总的来说,HACit-10微球满足了提出的设计标准,代表了一种有前途的GAE栓塞剂。意义声明:膝关节骨关节炎(OA)是最常见的关节疾病,疼痛是最突出的症状。膝动脉栓塞(GAE)为相当一部分(约20%)陷入治疗空白的OA患者提供了另一种选择-那些对保守治疗无反应但不适合全膝关节置换术的患者。透明质酸(HA)微球是开发gae指示的栓塞剂的有希望的候选者,因为基于HA的产品具有生物相容性,可生物降解,非免疫原性,并且fda批准用于关节内注射,促进临床转化。然而,仅通过调整交联剂浓度来实现尺寸、机械性能和降解时间的最佳平衡是具有挑战性的。本研究采用最近开发的盐处理方法来制造具有合适尺寸,增强机械强度和微调降解动力学的HA微球,为GAE量身定制。
{"title":"Biodegradable sodium citrate-treated hyaluronic acid microspheres for genicular artery embolization","authors":"Kierdra I. Dowling ,&nbsp;Tesnime Hidjir ,&nbsp;Lizhe Zhang ,&nbsp;Bianca Di Carlo ,&nbsp;Amid Shakeri ,&nbsp;Ka Kit Cheung ,&nbsp;Edmond W.K. Young ,&nbsp;Milica Radisic ,&nbsp;Mohammad Moeini ,&nbsp;Sebastian Mafeld ,&nbsp;Naomi Matsuura","doi":"10.1016/j.actbio.2026.01.003","DOIUrl":"10.1016/j.actbio.2026.01.003","url":null,"abstract":"<div><div>Genicular artery embolization (GAE) using microparticulate embolic agents has recently been shown to improve pain and function in knee osteoarthritis (OA) patients. Despite encouraging outcomes, current clinical embolics are repurposed from non-GAE applications and remain suboptimal due to non-degradability or non-spherical shape, highlighting a need for biodegradable microspherical embolics specifically designed for GAE. Here, we engineered 1,4-butanediol diglycidyl ether (BDDE)-crosslinked hyaluronic acid (HA) microspheres with properties fine-tuned for GAE using a salt treatment approach, targeting a size range of ∼75–300 μm and degradation time of ∼48 h. Sodium citrate (Cit)-treated HA (HACit) microspheres with tunable properties were fabricated via emulsion crosslinking in the presence of varying Cit concentrations (0–20% w/v, named HACit-0 to HACit-20). &gt;92% of microspheres measured between 75–300 µm. Treatment with 10% Cit (HACit-10) reduced the average microsphere size (from 195 ± 55 µm to 151 ± 53 µm), decreased the swelling ratio (from 24.3 ± 3.5 to 7.4 ± 0.1), and prolonged the <em>in vitro</em> degradation time (from 33 ± 3 h to 56 ± 4 h) compared to untreated microspheres (HACit-0). In a microfluidic occlusion test, HACit-10 microspheres exhibited enhanced strength to stably block microchannels, while HACit-0 microspheres failed to cause obstructions. NMR analysis verified complete Cit removal after microsphere washing, leaving FDA-approved BDDE-crosslinked HA as the sole embolic material. Cytotoxicity assessments using human umbilical vein endothelial cells (HUVECs) and human dermal fibroblasts (HDFs) demonstrated cytocompatibility of HACit-10 microspheres. Collectively, HACit-10 microspheres fulfilled the proposed design criteria, representing a promising embolic agent for GAE.</div></div><div><h3>Statement of significance</h3><div>Knee osteoarthritis (OA) is the most common joint disease, with pain being the most prominent symptom. Genicular artery embolization (GAE) provides an alternative option for a substantial subset (∼20%) of OA patients who fall into a treatment gap—those unresponsive to conservative treatments yet ineligible for total knee replacement. Hyaluronic acid (HA) microspheres are promising candidates for developing GAE-indicated embolics, as HA-based products are biocompatible, biodegradable, non-immunogenic, and FDA-approved for intra-articular injections, facilitating clinical translation. However, achieving an optimal balance of size, mechanical properties, and degradation time is challenging through crosslinker concentration adjustment alone. This study employs a recently developed salt treatment method to fabricate HA microspheres with suitable size, enhanced mechanical strength, and fine-tuned degradation kinetics, tailored for GAE.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"212 ","pages":"Pages 724-737"},"PeriodicalIF":9.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145936721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A biodegradable theranostic sonosensitizer for afterglow-guided sonodynamic therapy 一种用于余光引导声动力治疗的可生物降解治疗性声敏剂。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-03-01 Epub Date: 2026-01-05 DOI: 10.1016/j.actbio.2025.11.053
Chunbai Xiang , Chao Li , Yu Liu , Xing Yang , Jingjing Xiang , Chunbin Li , Ting Jiang , Yue Wang , Youjuan Wang , Safacan Kolemen , Qihang Ding , Pengfei Zhang , Ping Gong
Optical imaging is crucial in biology and medicine, yet fluorescence imaging suffers from poor tissue penetration, low signal-to-background ratio (SBR), and limited sensitivity/specificity. Ultrasound (US) imaging, being a non-invasive and widely used modality for anatomical and functional visualization, offers a promising source of activation for luminescence. However, designing degradable sonosensitizers for US-triggered afterglow emission remains challenging, necessitating efficient US-luminescence strategies. Here, we address this by developing a triphenylphosphonium cation (TPP⁺)-modified protoporphyrin IX derivative (PpIX-M). The TPP⁺ modification suppresses π-π stacking of the porphyrin plane, enhancing fluorescence quantum yield. Furthermore, TPP⁺ acts as an electron acceptor, promoting charge separation, prolonging phosphorescence lifetime, and thereby boosting reactive oxygen species (ROS) generation. Notably, PpIX-M achieves US-triggered Type I and II ROS-driven afterglow luminescence, with an afterglow lifetime reaching 20 min and an exceptional in vivo afterglow imaging SBR of 48.6. Under afterglow imaging guidance, effective sonodynamic therapy (SDT) was realized, inducing tumor cell ferroptosis and apoptosis. This study demonstrates the feasibility of TPP⁺-regulated fluorescence and ROS enhancement for ultrasound-induced luminescence imaging in vivo, offering valuable insights for the development of next-generation ultrasound-activated afterglow probes and advancing the field of ultrasound-based luminescence imaging.

Statement of significance

This work develops a sonosensitizer, PpIX-M, that integrates imaging and therapeutic functions. Its molecular design enhances key properties, allowing it to generate reactive oxygen species and produce a 20-minute afterglow under ultrasound. This enables high-contrast imaging while simultaneously delivering a sonodynamic therapy that triggers ferroptosis and apoptosis in cancer cells. The built-in self-degrading property of the agent reduces potential long-term toxicity. This combined approach provides a practical strategy for real-time treatment monitoring and precise tumor ablation.
光学成像在生物学和医学中至关重要,但荧光成像存在组织穿透性差、信号与背景比(SBR)低以及灵敏度/特异性有限的问题。超声成像作为一种无创且广泛应用于解剖和功能可视化的方式,提供了一种很有前途的发光激活源。然而,为us触发的余辉发射设计可降解的声敏剂仍然具有挑战性,需要有效的us发光策略。在这里,我们通过开发三苯基磷阳离子(TPP⁺)修饰的原卟啉IX衍生物(PpIX-M)来解决这个问题。TPP⁺修饰抑制了卟啉平面的π-π堆叠,提高了荧光量子产率。此外,TPP⁺作为电子受体,促进电荷分离,延长磷光寿命,从而促进活性氧(ROS)的生成。值得注意的是,PpIX-M实现了us触发的I型和II型ros驱动的余辉发光,余辉寿命达到20分钟,体内余辉成像SBR达到48.6。在余辉成像引导下,实现有效的声动力治疗(SDT),诱导肿瘤细胞铁下垂和凋亡。本研究证明了TPP⁺调控荧光和ROS增强用于超声诱导的体内发光成像的可行性,为开发下一代超声激活余辉探针和推进基于超声的发光成像领域提供了有价值的见解。意义声明:这项工作开发了一种超声敏化剂PpIX-M,它集成了成像和治疗功能。它的分子设计增强了关键性能,使其能够产生活性氧,并在超声波下产生20分钟的余辉。这可以实现高对比度成像,同时提供触发铁下垂和癌细胞凋亡的声动力治疗。该剂内置的自降解特性降低了潜在的长期毒性。这种联合方法为实时治疗监测和精确肿瘤消融提供了实用的策略。
{"title":"A biodegradable theranostic sonosensitizer for afterglow-guided sonodynamic therapy","authors":"Chunbai Xiang ,&nbsp;Chao Li ,&nbsp;Yu Liu ,&nbsp;Xing Yang ,&nbsp;Jingjing Xiang ,&nbsp;Chunbin Li ,&nbsp;Ting Jiang ,&nbsp;Yue Wang ,&nbsp;Youjuan Wang ,&nbsp;Safacan Kolemen ,&nbsp;Qihang Ding ,&nbsp;Pengfei Zhang ,&nbsp;Ping Gong","doi":"10.1016/j.actbio.2025.11.053","DOIUrl":"10.1016/j.actbio.2025.11.053","url":null,"abstract":"<div><div>Optical imaging is crucial in biology and medicine, yet fluorescence imaging suffers from poor tissue penetration, low signal-to-background ratio (SBR), and limited sensitivity/specificity. Ultrasound (US) imaging, being a non-invasive and widely used modality for anatomical and functional visualization, offers a promising source of activation for luminescence. However, designing degradable sonosensitizers for US-triggered afterglow emission remains challenging, necessitating efficient US-luminescence strategies. Here, we address this by developing a triphenylphosphonium cation (TPP⁺)-modified protoporphyrin IX derivative (<strong>PpIX-M</strong>). The TPP⁺ modification suppresses π-π stacking of the porphyrin plane, enhancing fluorescence quantum yield. Furthermore, TPP⁺ acts as an electron acceptor, promoting charge separation, prolonging phosphorescence lifetime, and thereby boosting reactive oxygen species (ROS) generation. Notably, <strong>PpIX-M</strong> achieves US-triggered Type I and II ROS-driven afterglow luminescence, with an afterglow lifetime reaching 20 min and an exceptional <em>in vivo</em> afterglow imaging SBR of 48.6. Under afterglow imaging guidance, effective sonodynamic therapy (SDT) was realized, inducing tumor cell ferroptosis and apoptosis. This study demonstrates the feasibility of TPP⁺-regulated fluorescence and ROS enhancement for ultrasound-induced luminescence imaging <em>in vivo</em>, offering valuable insights for the development of next-generation ultrasound-activated afterglow probes and advancing the field of ultrasound-based luminescence imaging.</div></div><div><h3>Statement of significance</h3><div>This work develops a sonosensitizer, PpIX-M, that integrates imaging and therapeutic functions. Its molecular design enhances key properties, allowing it to generate reactive oxygen species and produce a 20-minute afterglow under ultrasound. This enables high-contrast imaging while simultaneously delivering a sonodynamic therapy that triggers ferroptosis and apoptosis in cancer cells. The built-in self-degrading property of the agent reduces potential long-term toxicity. This combined approach provides a practical strategy for real-time treatment monitoring and precise tumor ablation.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"212 ","pages":"Pages 695-708"},"PeriodicalIF":9.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145919392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fluorinated ROS-responsive polycation enables noninvasive siRNA Delivery for the treatment of corneal neovascularization 氟化ros反应多阳离子可实现无创siRNA递送治疗角膜新生血管。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-03-01 Epub Date: 2026-01-13 DOI: 10.1016/j.actbio.2026.01.023
Yifei Chen , Xin Wang , Yong Duan , Lu Liu , Ruixiang Chen , Yufeng Huang , Yongjuan Tan , Qunzan Lu , Quankui Lin , Liangliang Shen
Corneal neovascularization (CNV) is a vision-threatening condition characterized by abnormal blood vessel growth into the avascular cornea, impairing its transparency and visual function. CNV is driven by an imbalance between pro- and anti-angiogenic factors, notably the overexpression of vascular endothelial growth factor (VEGF), exacerbated by inflammation and oxidative stress. Current treatments, including anti-VEGF and anti-inflammatory agents, are limited by poor bioavailability and invasive administration. In this study, we developed a fluorinated polycation for non-invasive delivery of siVEGFA along with ROS scavenging functionality to combat CNV. This multifunctional polymer exhibits enhanced ocular surface penetration via fluorination effect, efficient siRNA binding and delivery, and ROS-scavenging capacity. It demonstrated high biocompatibility, suppressed VEGFA expression, and significantly inhibited CNV progression in a mouse alkali burn model. These results highlight the promise of fluorinated, stimuli-responsive polymers as a dual-functional platform for safe, effective, and non-invasive treatment of ocular neovascular disorders.

Statement of Significance

CNV is a major cause of vision loss, yet current treatments rely on invasive injections or anti-inflammatory drugs, which can hinder corneal healing and reduce patient compliance. This study presents a fluorinated, ROS-responsive polycation that enables non-invasive, topical siRNA delivery while simultaneously combatting oxidative stress. Unlike conventional carriers, fluorination improves ocular penetration and intracellular delivery. By combining VEGFA knockdown with intrinsic antioxidant activity, this platform effectively suppresses neovascularization without delaying epithelial repair. This study advances the field of ocular gene therapy by offering a safer, injection-free alternative. It also highlights the potential of multifunctional polymer systems for treating chronic ocular vascular diseases.
角膜新生血管(CNV)是一种威胁视力的疾病,其特征是异常血管生长到无血管的角膜,损害其透明度和视觉功能。CNV是由促血管生成因子和抗血管生成因子之间的不平衡驱动的,尤其是血管内皮生长因子(VEGF)的过度表达,炎症和氧化应激加剧了这种不平衡。目前的治疗方法,包括抗vegf和抗炎药物,由于生物利用度差和侵入性给药而受到限制。在这项研究中,我们开发了一种氟化多阳离子,用于无创递送siVEGFA,同时具有清除ROS的功能,以对抗CNV。该多功能聚合物具有通过氟化效应增强眼表穿透能力、高效的siRNA结合和传递能力以及ros清除能力。在小鼠碱烧伤模型中表现出高生物相容性,抑制VEGFA表达,显著抑制CNV进展。这些结果突出了氟化,刺激反应聚合物作为安全,有效和非侵入性治疗眼部新生血管疾病的双重功能平台的前景。意义声明:CNV是视力丧失的主要原因,但目前的治疗依赖于侵入性注射或抗炎药物,这可能会阻碍角膜愈合并降低患者的依从性。本研究提出了一种氟化,ros反应多阳离子,使非侵入性,局部siRNA递送,同时对抗氧化应激。与传统载体不同,氟化可改善眼内穿透和细胞内递送。通过将VEGFA敲除与内在抗氧化活性相结合,该平台有效抑制新生血管而不延迟上皮修复。这项研究通过提供一种更安全、无需注射的替代方法,推动了眼部基因治疗领域的发展。这也突出了多功能聚合物系统治疗慢性眼部血管疾病的潜力。
{"title":"Fluorinated ROS-responsive polycation enables noninvasive siRNA Delivery for the treatment of corneal neovascularization","authors":"Yifei Chen ,&nbsp;Xin Wang ,&nbsp;Yong Duan ,&nbsp;Lu Liu ,&nbsp;Ruixiang Chen ,&nbsp;Yufeng Huang ,&nbsp;Yongjuan Tan ,&nbsp;Qunzan Lu ,&nbsp;Quankui Lin ,&nbsp;Liangliang Shen","doi":"10.1016/j.actbio.2026.01.023","DOIUrl":"10.1016/j.actbio.2026.01.023","url":null,"abstract":"<div><div>Corneal neovascularization (CNV) is a vision-threatening condition characterized by abnormal blood vessel growth into the avascular cornea, impairing its transparency and visual function. CNV is driven by an imbalance between pro- and anti-angiogenic factors, notably the overexpression of vascular endothelial growth factor (VEGF), exacerbated by inflammation and oxidative stress. Current treatments, including anti-VEGF and anti-inflammatory agents, are limited by poor bioavailability and invasive administration. In this study, we developed a fluorinated polycation for non-invasive delivery of siVEGFA along with ROS scavenging functionality to combat CNV. This multifunctional polymer exhibits enhanced ocular surface penetration via fluorination effect, efficient siRNA binding and delivery, and ROS-scavenging capacity. It demonstrated high biocompatibility, suppressed VEGFA expression, and significantly inhibited CNV progression in a mouse alkali burn model. These results highlight the promise of fluorinated, stimuli-responsive polymers as a dual-functional platform for safe, effective, and non-invasive treatment of ocular neovascular disorders.</div></div><div><h3>Statement of Significance</h3><div>CNV is a major cause of vision loss, yet current treatments rely on invasive injections or anti-inflammatory drugs, which can hinder corneal healing and reduce patient compliance. This study presents a fluorinated, ROS-responsive polycation that enables non-invasive, topical siRNA delivery while simultaneously combatting oxidative stress. Unlike conventional carriers, fluorination improves ocular penetration and intracellular delivery. By combining VEGFA knockdown with intrinsic antioxidant activity, this platform effectively suppresses neovascularization without delaying epithelial repair. This study advances the field of ocular gene therapy by offering a safer, injection-free alternative. It also highlights the potential of multifunctional polymer systems for treating chronic ocular vascular diseases.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"212 ","pages":"Pages 754-769"},"PeriodicalIF":9.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145992250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A biodegradable high-purity magnesium closing clip for general surgery 一种用于普通外科手术的可生物降解的高纯度镁封闭夹。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-03-01 Epub Date: 2025-11-21 DOI: 10.1016/j.actbio.2025.11.040
Jiahua Ni , Wenhui Wang , Haidong Xu , Man Jiang , Xin Liu , Yawen Lou , Jun Yan , Yigang Chen , Xiaonong Zhang
The commonly used closing clips do not fully meet clinical requirements. For instance, non-degradable titanium and plastic clips remain in the body permanently, resulting in tissue lesions due to prolonged stimulation of the surrounding tissues, and degradable polymer clips typically possess weak mechanical properties and may produce irritating degradation products. In this work, we report a promising, multifunctional, and degradable high-purity magnesium (HP-Mg) closing clip to conquer the limitations of existing clinical closing clips. The HP-Mg closing clips possess enhanced clamping capabilities, effectively avoiding hemorrhage, tissue fluid leakage, clip loosening and slipping, as well as complete degradability within approximately 360 days in vivo, mitigating the risk of permanent foreign body retention. The Mg2+ released from HP-Mg clips significantly promotes collagen synthesis in vascular smooth muscle, accelerating wound healing. Moreover, Mg2+ and H2 released from the HP-Mg clips significantly induce the apoptosis of tumor cells. In vivo mouse, rat, and minipig models validate that the degradation products of HP-Mg clips are absorbed and metabolized by tissues, and do not cause Mg2+ or H2 accumulation in major organs, pH value deviation of local tissues, severe local and systemic inflammation reactions, or artifacts in an imaging test. The self-developed biodegradable Mg closing clip received NMPA approval for marketing as a Class III medical device in 2023. The biodegradable HP-Mg closing clips offer a promising alternative to current clinical closing clips for the tubular tissues that do not require permanent closure force in laparoscopic surgery.

Statement of significance

1. We designed a biodegradable high-purity magnesium (HP-Mg) closing clip for laparoscopic surgery. It shows effective closure, complete biodegradability in vivo, no adverse reactions, and multiple biofunctions.
2. HP-Mg clips overcome limitations of current clips: non-degradable clips may cause tissue lesions, while degradable polymer clips possess weak mechanical properties and may release irritants.
3. The released Mg2+ promotes collagen synthesis, accelerating wound healing. The released Mg2+ and H2 also induce tumor cell apoptosis.
4. HP-Mg clip was issued as an innovative medical device (Innovation No.: 201,800,018) by China’s NMPA in 2018 and approved for marketing (License No.: 20,233,021,931) as a Class III medical device in 2023. It is China’s first bio-Mg implant and the world's first biodegradable Mg closing clip.
常用的闭合夹不能完全满足临床要求。例如,不可降解的钛和塑料夹子永久留在体内,由于对周围组织的长时间刺激而导致组织损伤,而可降解的聚合物夹子通常具有较弱的机械性能,并且可能产生刺激性降解产物。在这项工作中,我们报告了一种有前途的,多功能的,可降解的高纯度镁(HP-Mg)闭合夹,以克服现有临床闭合夹的局限性。HP-Mg闭合夹具有增强的夹紧能力,有效避免出血、组织液泄漏、夹子松动和滑动,并且在体内约360天内完全降解,降低了永久异物滞留的风险。HP-Mg夹子释放的Mg2+显著促进血管平滑肌胶原合成,加速伤口愈合。此外,HP-Mg片段释放的Mg2+和H2显著诱导肿瘤细胞凋亡。小鼠、大鼠和小型猪的体内模型验证了HP-Mg夹片的降解产物被组织吸收和代谢,不会引起Mg2+或H2在主要器官的积累、局部组织的pH值偏差、严重的局部和全身炎症反应,也不会在影像学检查中出现假影。自主研发的可生物降解Mg闭合夹于2023年获得国家药监局批准,作为III类医疗器械上市。可生物降解的HP-Mg闭合夹为腹腔镜手术中不需要永久闭合力的管状组织提供了一种有希望的替代临床闭合夹。意义陈述:1;我们设计了一种可生物降解的高纯度镁(HP-Mg)腹腔镜手术闭合夹。具有封闭有效、体内完全生物降解、无不良反应、多种生物功能等特点。2. HP-Mg夹子克服了现有夹子的局限性:不可降解的夹子可能造成组织损伤,而可降解的聚合物夹子机械性能弱,可能释放刺激物。3. 释放的Mg2+促进胶原合成,加速伤口愈合。释放的Mg2+和H2也能诱导肿瘤细胞凋亡。4. HP-Mg夹作为创新医疗器械(创新号:编号:201800018)于2018年通过国家药监局审批,获准上市销售(许可证号:201800018)。: 20233021931)在2023年被列为III类医疗器械。这是中国第一个生物镁植入物,也是世界上第一个生物可降解的镁闭合夹。
{"title":"A biodegradable high-purity magnesium closing clip for general surgery","authors":"Jiahua Ni ,&nbsp;Wenhui Wang ,&nbsp;Haidong Xu ,&nbsp;Man Jiang ,&nbsp;Xin Liu ,&nbsp;Yawen Lou ,&nbsp;Jun Yan ,&nbsp;Yigang Chen ,&nbsp;Xiaonong Zhang","doi":"10.1016/j.actbio.2025.11.040","DOIUrl":"10.1016/j.actbio.2025.11.040","url":null,"abstract":"<div><div>The commonly used closing clips do not fully meet clinical requirements. For instance, non-degradable titanium and plastic clips remain in the body permanently, resulting in tissue lesions due to prolonged stimulation of the surrounding tissues, and degradable polymer clips typically possess weak mechanical properties and may produce irritating degradation products. In this work, we report a promising, multifunctional, and degradable high-purity magnesium (HP-Mg) closing clip to conquer the limitations of existing clinical closing clips. The HP-Mg closing clips possess enhanced clamping capabilities, effectively avoiding hemorrhage, tissue fluid leakage, clip loosening and slipping, as well as complete degradability within approximately 360 days <em>in vivo,</em> mitigating the risk of permanent foreign body retention. The Mg<sup>2+</sup> released from HP-Mg clips significantly promotes collagen synthesis in vascular smooth muscle, accelerating wound healing. Moreover, Mg<sup>2+</sup> and H<sub>2</sub> released from the HP-Mg clips significantly induce the apoptosis of tumor cells. <em>In vivo</em> mouse, rat, and minipig models validate that the degradation products of HP-Mg clips are absorbed and metabolized by tissues, and do not cause Mg<sup>2+</sup> or H<sub>2</sub> accumulation in major organs, pH value deviation of local tissues, severe local and systemic inflammation reactions, or artifacts in an imaging test. The self-developed biodegradable Mg closing clip received NMPA approval for marketing as a Class III medical device in 2023. The biodegradable HP-Mg closing clips offer a promising alternative to current clinical closing clips for the tubular tissues that do not require permanent closure force in laparoscopic surgery.</div></div><div><h3>Statement of significance</h3><div>1. We designed a biodegradable high-purity magnesium (HP-Mg) closing clip for laparoscopic surgery. It shows effective closure, complete biodegradability <em>in vivo</em>, no adverse reactions, and multiple biofunctions.</div><div>2. HP-Mg clips overcome limitations of current clips: non-degradable clips may cause tissue lesions, while degradable polymer clips possess weak mechanical properties and may release irritants.</div><div>3. The released Mg<sup>2+</sup> promotes collagen synthesis, accelerating wound healing. The released Mg<sup>2+</sup> and H<sub>2</sub> also induce tumor cell apoptosis.</div><div>4. HP-Mg clip was issued as an innovative medical device (Innovation No.: 201,800,018) by China’s NMPA in 2018 and approved for marketing (License No.: 20,233,021,931) as a Class III medical device in 2023. It is China’s first bio-Mg implant and the world's first biodegradable Mg closing clip.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"212 ","pages":"Pages 829-843"},"PeriodicalIF":9.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145590104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-destructive assessment of multi-material micro-tissue mechanics reveals the critical role of rigidity gradients in tumour growth and pressure 多材料微组织力学的非破坏性评估揭示了刚度梯度在肿瘤生长和压力中的关键作用。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-03-01 Epub Date: 2025-12-12 DOI: 10.1016/j.actbio.2025.12.013
Angélique Ala , Camille Douillet , Audrey Ferrand , Vincent Velay , Stéphane Segonds , Gaëlle Recher , Florian Bugarin
Probing stiffness anisotropies in three-dimensional materials non-destructively is a major challenge in disciplines as diverse as aeronautics and medicine. While the former typically relies on various mechanical tests—such as tensile, compression, bending, and shear—performed on sample parts, the latter often employs acoustic techniques or wave propagation through matter. The choice of techniques depends on the size of the sample of interest and the desired resolution. In our case, to probe the mechanical properties of sub-millimetre micro-tissues, it is necessary to use methods with high resolution and as furtive as possible. We present a method based, 1/ on imaging the displacement of microbeads within a hydrogel resulting from the growth of a three-dimensional micro-tissue and, 2/ on finite element modelling of the deformations underlying bead displacements. This approach allows us to determine the elastic properties of the hydrogel and, in particular, to show that beyond a certain thickness, incomplete cross-linking of the hydrogel results in a stiffness gradient. We show that when the micro-tissue contacts with an immediately rigid alginate wall, the pressure exerted over time increases very rapidly, whereas when the micro-tissue encounters a substrate with a stiffness gradient, the pressure increase is more gradual. Uncovering this could provide a better understanding of the role of tumour microenvironment stiffness in metastatic escape processes.

Statement of significance

Understanding factors modulating tumours growth is crucial for developing better cancer treatments. This study introduces a non-destructive method to assess the stiffness of subcomponents of a tissue avatar, a question unwieldly to tackle. The authors show that small changes in stiffness of the tumour-mimic surrounding tissue can strongly affects how the tumour cell aggregate grows. This is an outreach in cancer biology because it connects the mechanical environment of tissues to cancer behaviour in a original way. It provides a powerful tool for studying 3D biological systems and could help design more suited materials for biomedical research and therapy. This work is relevant for the fields of cancer biology, biomaterials, and tissue engineering.
非破坏性地探测三维材料的刚度各向异性是航空和医学等学科的主要挑战。前者通常依赖于对样品部件进行的各种机械测试,如拉伸、压缩、弯曲和剪切,而后者通常采用声学技术或通过物质的波传播。技术的选择取决于感兴趣的样本的大小和期望的分辨率。在我们的案例中,为了探测亚毫米微观组织的力学性能,有必要使用高分辨率和尽可能隐蔽的方法。我们提出了一种方法,1/对水凝胶中由三维微组织生长引起的微珠位移进行成像,2/对微珠位移下的变形进行有限元建模。这种方法使我们能够确定水凝胶的弹性特性,特别是表明,超过一定厚度,水凝胶的不完全交联会导致刚度梯度。我们表明,当微组织与立即刚性藻酸盐壁接触时,施加的压力随着时间的推移而迅速增加,而当微组织遇到具有刚度梯度的底物时,压力增加更为缓慢。揭示这一点可以更好地理解肿瘤微环境刚度在转移性逃逸过程中的作用。意义声明:了解调节肿瘤生长的因素对于开发更好的癌症治疗方法至关重要。本研究引入了一种非破坏性的方法来评估组织头像的子组件的刚度,这是一个难以解决的问题。作者表明,肿瘤模拟周围组织硬度的微小变化可以强烈影响肿瘤细胞聚集的生长方式。这是癌症生物学的延伸,因为它以一种原始的方式将组织的机械环境与癌症行为联系起来。它为研究3D生物系统提供了一个强大的工具,可以帮助设计更适合生物医学研究和治疗的材料。这项工作涉及癌症生物学、生物材料和组织工程等领域。
{"title":"Non-destructive assessment of multi-material micro-tissue mechanics reveals the critical role of rigidity gradients in tumour growth and pressure","authors":"Angélique Ala ,&nbsp;Camille Douillet ,&nbsp;Audrey Ferrand ,&nbsp;Vincent Velay ,&nbsp;Stéphane Segonds ,&nbsp;Gaëlle Recher ,&nbsp;Florian Bugarin","doi":"10.1016/j.actbio.2025.12.013","DOIUrl":"10.1016/j.actbio.2025.12.013","url":null,"abstract":"<div><div>Probing stiffness anisotropies in three-dimensional materials non-destructively is a major challenge in disciplines as diverse as aeronautics and medicine. While the former typically relies on various mechanical tests—such as tensile, compression, bending, and shear—performed on sample parts, the latter often employs acoustic techniques or wave propagation through matter. The choice of techniques depends on the size of the sample of interest and the desired resolution. In our case, to probe the mechanical properties of sub-millimetre micro-tissues, it is necessary to use methods with high resolution and as furtive as possible. We present a method based, 1/ on imaging the displacement of microbeads within a hydrogel resulting from the growth of a three-dimensional micro-tissue and, 2/ on finite element modelling of the deformations underlying bead displacements. This approach allows us to determine the elastic properties of the hydrogel and, in particular, to show that beyond a certain thickness, incomplete cross-linking of the hydrogel results in a stiffness gradient. We show that when the micro-tissue contacts with an immediately rigid alginate wall, the pressure exerted over time increases very rapidly, whereas when the micro-tissue encounters a substrate with a stiffness gradient, the pressure increase is more gradual. Uncovering this could provide a better understanding of the role of tumour microenvironment stiffness in metastatic escape processes.</div></div><div><h3>Statement of significance</h3><div>Understanding factors modulating tumours growth is crucial for developing better cancer treatments. This study introduces a non-destructive method to assess the stiffness of subcomponents of a tissue avatar, a question unwieldly to tackle. The authors show that small changes in stiffness of the tumour-mimic surrounding tissue can strongly affects how the tumour cell aggregate grows. This is an outreach in cancer biology because it connects the mechanical environment of tissues to cancer behaviour in a original way. It provides a powerful tool for studying 3D biological systems and could help design more suited materials for biomedical research and therapy. This work is relevant for the fields of cancer biology, biomaterials, and tissue engineering.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"212 ","pages":"Pages 383-398"},"PeriodicalIF":9.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145758494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A silk fibroin/tannic acid hydrogel with acid-enhanced adhesion and procoagulant nanofiber reinforcement for gastric hemorrhage management 具有酸增强黏附和促凝纳米纤维增强的丝素/单宁酸水凝胶用于胃出血治疗。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-03-01 Epub Date: 2025-12-23 DOI: 10.1016/j.actbio.2025.12.043
Qing Li , Xuanqi Wang , Kun Yu , Yanqiu Leng , Yongchao Wang , Zhihang Zhou , Fangyin Dai , Guangqian Lan
Effective endoscopic management of gastric hemorrhage necessitates a hemostat with rapid coagulation capabilities and sustained protection against gastric acid erosion. This study demonstrates that silk fibroin-tannic acid (SF-TA), which exhibits unique acid-triggered adhesion enhancement under acidic conditions, serves as a potential foundation for gastric hemorrhage management. This supramolecular structure displays an enhanced adhesion pattern to epithelial keratin-2 (EKRT2) at pH 1. The weakened electrostatic shielding effect and the rearrangement of water molecules induced by H⁺ significantly enhance the electrostatic interactions and van der Waals forces between the functional groups (-NH₂, -COOH, and Ar-OH) of SF-TA and EKRT2. This results in an over 50 % increase in adhesion strength under simulated gastric fluid (SGF, pH 1.3) compared to that in PBS (pH 7.3). The β-sheet repeat domain of SF offers a stable conformation, facilitating strong binding with TA, thereby maintaining integrity in gastric fluid for over 5 days. SF-TA is further reinforced with procoagulant silk fibroin nanofibers/protein corona (SFNPC), enabling rapid control of pig gastrorrhagia within 2 min, providing persistent protection in gastric fluid to prevent rebleeding, and facilitating gastric mucosal healing within 5 days. This study reveals the acid-triggered enhanced adhesion pattern of silk fibroin/tannic acid, offering a feasible approach for the further development of biomaterials for long-term gastric hemorrhage and conditions management.

Statement of significance

This work presents a biomaterial-based hemostat with transformative potential for managing gastric hemorrhage. Its significance lies in the unique acid-triggered adhesive mechanism of the silk fibroin-tannic acid (SF-TA) complex, which exhibits enhanced adhesion to mucosal proteins under extreme gastric acidity (pH 1), a critical limitation of existing hemostatic agents. This supramolecular system ensures robust, long-lasting cohesion for over 5 days. Furthermore, when reinforced with procoagulant nanofibers (SFNPC), it achieves rapid hemostasis, provides a durable physical barrier against acid erosion and rebleeding, and actively promotes mucosal healing. This technology offers a comprehensive and efficient therapeutic strategy, addressing the key challenges of rapid coagulation and sustained protection in the harsh gastric environment.
胃出血的有效内镜管理需要止血药具有快速凝血能力和持续保护胃酸侵蚀。本研究表明,丝素-单宁酸(SF-TA)在酸性条件下表现出独特的酸触发粘附增强,可作为胃出血治疗的潜在基础。这种超分子结构在pH为1时对上皮角蛋白-2 (EKRT2)表现出增强的粘附模式。H⁺导致的静电屏蔽效应减弱和水分子重排显著增强了SF-TA和EKRT2官能团(-NH₂、-COOH和Ar-OH)之间的静电相互作用和范德华力。这导致在模拟胃液(SGF, pH 1.3)下的粘附强度比在PBS (pH 7.3)下的粘附强度增加50%以上。SF的β-sheet重复结构域提供稳定的构象,促进与TA的强结合,从而在胃液中保持完整性超过5天。SF-TA进一步加入促凝丝素纳米纤维/蛋白冠(SFNPC),可在2分钟内快速控制猪胃出血,在胃液中提供持续保护以防止再出血,并促进胃粘膜在5天内愈合。本研究揭示了酸触发的丝素/单宁酸增强粘附模式,为进一步开发用于长期胃出血的生物材料和治疗提供了可行的途径。意义声明:这项工作提出了一种基于生物材料的止血剂,具有治疗胃出血的变革性潜力。其意义在于丝素-单宁酸(SF-TA)复合物独特的酸触发粘附机制,在极端胃酸(pH 1)条件下,对粘膜蛋白的粘附增强,这是现有止血剂的一个关键限制。这种超分子系统可确保5天以上的持久凝聚力。此外,当使用促凝纳米纤维(SFNPC)增强时,它可以实现快速止血,为酸侵蚀和再出血提供持久的物理屏障,并积极促进粘膜愈合。这项技术提供了一种全面有效的治疗策略,解决了在恶劣的胃环境中快速凝固和持续保护的关键挑战。
{"title":"A silk fibroin/tannic acid hydrogel with acid-enhanced adhesion and procoagulant nanofiber reinforcement for gastric hemorrhage management","authors":"Qing Li ,&nbsp;Xuanqi Wang ,&nbsp;Kun Yu ,&nbsp;Yanqiu Leng ,&nbsp;Yongchao Wang ,&nbsp;Zhihang Zhou ,&nbsp;Fangyin Dai ,&nbsp;Guangqian Lan","doi":"10.1016/j.actbio.2025.12.043","DOIUrl":"10.1016/j.actbio.2025.12.043","url":null,"abstract":"<div><div>Effective endoscopic management of gastric hemorrhage necessitates a hemostat with rapid coagulation capabilities and sustained protection against gastric acid erosion. This study demonstrates that silk fibroin-tannic acid (SF-TA), which exhibits unique acid-triggered adhesion enhancement under acidic conditions, serves as a potential foundation for gastric hemorrhage management. This supramolecular structure displays an enhanced adhesion pattern to epithelial keratin-2 (EKRT2) at pH 1. The weakened electrostatic shielding effect and the rearrangement of water molecules induced by H⁺ significantly enhance the electrostatic interactions and van der Waals forces between the functional groups (-NH₂, -COOH, and Ar-OH) of SF-TA and EKRT2. This results in an over 50 % increase in adhesion strength under simulated gastric fluid (SGF, pH 1.3) compared to that in PBS (pH 7.3). The β-sheet repeat domain of SF offers a stable conformation, facilitating strong binding with TA, thereby maintaining integrity in gastric fluid for over 5 days. SF-TA is further reinforced with procoagulant silk fibroin nanofibers/protein corona (SFNPC), enabling rapid control of pig gastrorrhagia within 2 min, providing persistent protection in gastric fluid to prevent rebleeding, and facilitating gastric mucosal healing within 5 days. This study reveals the acid-triggered enhanced adhesion pattern of silk fibroin/tannic acid, offering a feasible approach for the further development of biomaterials for long-term gastric hemorrhage and conditions management.</div></div><div><h3>Statement of significance</h3><div>This work presents a biomaterial-based hemostat with transformative potential for managing gastric hemorrhage. Its significance lies in the unique acid-triggered adhesive mechanism of the silk fibroin-tannic acid (SF-TA) complex, which exhibits enhanced adhesion to mucosal proteins under extreme gastric acidity (pH 1), a critical limitation of existing hemostatic agents. This supramolecular system ensures robust, long-lasting cohesion for over 5 days. Furthermore, when reinforced with procoagulant nanofibers (SFNPC), it achieves rapid hemostasis, provides a durable physical barrier against acid erosion and rebleeding, and actively promotes mucosal healing. This technology offers a comprehensive and efficient therapeutic strategy, addressing the key challenges of rapid coagulation and sustained protection in the harsh gastric environment.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"212 ","pages":"Pages 235-250"},"PeriodicalIF":9.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145835457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nucleoside-stabilized stimuli-responsive lipoic acid supramolecular hydrogel: An efficacious antioxidant and antibacterial platform for chronic diabetic wound repair 核苷稳定刺激反应硫辛酸超分子水凝胶:慢性糖尿病伤口修复的有效抗氧化和抗菌平台。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-03-01 Epub Date: 2026-01-07 DOI: 10.1016/j.actbio.2026.01.007
Chunyue Zhao , Tong Wu , Enchang Liu , Fangzheng Zhao , Qiqi Han , Zhen Wang , Rijie Wang , Tingbin Zhang , Jinfeng Xing
Diabetic wound healing remains a critical clinical challenge due to persistent oxidative stress, recurrent infections, and dysregulated inflammation within the wound microenvironment. Consequently, it is desirable to develop advanced dressings capable of microenvironment-adaptive therapy to simultaneously address these pathological conditions. Herein, an innovative guanosine (G4)-stabilized lipoic acid (LA)-based supramolecular hydrogel integrating LA and G4 is fabricated through a one-step assembly. This design pioneers a dynamic stabilization strategy wherein the G4 network’s multivalent hydrogen bonds prevent reverse ring-opening depolymerization of polylipoic acid (PolyLA) while enabling on-demand reversible disulfide reconfiguration, thereby overcoming the stability-depolymerization imbalance in conventional LA-based hydrogels. Furthermore, by modulating the content of LA, two types of hydrogels including injectable hydrogels and patch hydrogels are developed tailored for meeting different clinical applications. Both in vitro and in vivo studies demonstrate that these hydrogels exhibit multiple responsiveness, potent reactive oxygen species (ROS) scavenging capacity, significant anti-inflammatory activity, and antibacterial properties, thereby facilitating the healing of diabetic wounds. This innovative approach not only addresses the inherent instability of LA-based hydrogels but also establishes an effective responsive therapeutic platform for chronic wound management.

Statement of significance

A newly developed approach addresses the reverse ring-opening depopolymerization of polylipoic acid by employing a guanosine supramolecular network for stabilization. The guanosine network provides robust stabilization while exhibiting multi-stimuli responsiveness, enabling a controllable reverse depolymerization of polylipoic acid that surpasses conventional unidirectional strategies. Importantly, the synthesis conditions for the guanosine network and polylipoic acid are nearly identical, as both require an alkaline pH and elevated temperature. This compatibility allows direct hydrogel formation through a simple process of mixing, heating, and cooling. The resulting hydrogel capitalizes on the inherent biological activities of both lipoic acid and guanosine, demonstrating potent antioxidant and antimicrobial properties alongside multi-stimuli responsiveness for diabetic wound management.
由于持续的氧化应激、复发性感染和伤口微环境中的炎症失调,糖尿病伤口愈合仍然是一个关键的临床挑战。因此,需要开发先进的敷料能够微环境适应性治疗,同时解决这些病理条件。本文通过一步组装制备了一种新型的鸟苷(G4)稳定硫辛酸(LA)基超分子水凝胶。该设计开创了一种动态稳定策略,其中G4网络的多价氢键阻止了聚硫酸(PolyLA)的反开环解聚,同时实现了按需可逆的二硫重新配置,从而克服了传统la基水凝胶的稳定性-解聚不平衡。此外,通过调节LA的含量,开发出两种类型的水凝胶,包括注射水凝胶和贴片水凝胶,以满足不同的临床应用。体外和体内研究表明,这些水凝胶具有多种反应性,有效的活性氧(ROS)清除能力,显著的抗炎活性和抗菌特性,从而促进糖尿病伤口的愈合。这种创新的方法不仅解决了la基水凝胶固有的不稳定性,而且为慢性伤口管理建立了一个有效的反应性治疗平台。意义声明:一种新开发的方法通过采用鸟苷超分子网络来稳定聚硫辛酸的反开环解聚。鸟苷网络提供了强大的稳定性,同时表现出多刺激响应性,使聚硫辛酸的可控反向解聚优于传统的单向策略。重要的是,鸟苷网络和聚硫辛酸的合成条件几乎相同,都需要碱性pH和高温。这种相容性允许通过简单的混合、加热和冷却过程直接形成水凝胶。由此产生的水凝胶利用硫辛酸和鸟苷的固有生物活性,显示出有效的抗氧化和抗菌特性,以及糖尿病伤口管理的多重刺激反应性。
{"title":"Nucleoside-stabilized stimuli-responsive lipoic acid supramolecular hydrogel: An efficacious antioxidant and antibacterial platform for chronic diabetic wound repair","authors":"Chunyue Zhao ,&nbsp;Tong Wu ,&nbsp;Enchang Liu ,&nbsp;Fangzheng Zhao ,&nbsp;Qiqi Han ,&nbsp;Zhen Wang ,&nbsp;Rijie Wang ,&nbsp;Tingbin Zhang ,&nbsp;Jinfeng Xing","doi":"10.1016/j.actbio.2026.01.007","DOIUrl":"10.1016/j.actbio.2026.01.007","url":null,"abstract":"<div><div>Diabetic wound healing remains a critical clinical challenge due to persistent oxidative stress, recurrent infections, and dysregulated inflammation within the wound microenvironment. Consequently, it is desirable to develop advanced dressings capable of microenvironment-adaptive therapy to simultaneously address these pathological conditions. Herein, an innovative guanosine (G<sub>4</sub>)-stabilized lipoic acid (LA)-based supramolecular hydrogel integrating LA and G<sub>4</sub> is fabricated through a one-step assembly. This design pioneers a dynamic stabilization strategy wherein the G<sub>4</sub> network’s multivalent hydrogen bonds prevent reverse ring-opening depolymerization of polylipoic acid (PolyLA) while enabling on-demand reversible disulfide reconfiguration, thereby overcoming the stability-depolymerization imbalance in conventional LA-based hydrogels. Furthermore, by modulating the content of LA, two types of hydrogels including injectable hydrogels and patch hydrogels are developed tailored for meeting different clinical applications. Both <em>in vitro</em> and <em>in vivo</em> studies demonstrate that these hydrogels exhibit multiple responsiveness, potent reactive oxygen species (ROS) scavenging capacity, significant anti-inflammatory activity, and antibacterial properties, thereby facilitating the healing of diabetic wounds. This innovative approach not only addresses the inherent instability of LA-based hydrogels but also establishes an effective responsive therapeutic platform for chronic wound management.</div></div><div><h3>Statement of significance</h3><div>A newly developed approach addresses the reverse ring-opening depopolymerization of polylipoic acid by employing a guanosine supramolecular network for stabilization. The guanosine network provides robust stabilization while exhibiting multi-stimuli responsiveness, enabling a controllable reverse depolymerization of polylipoic acid that surpasses conventional unidirectional strategies. Importantly, the synthesis conditions for the guanosine network and polylipoic acid are nearly identical, as both require an alkaline pH and elevated temperature. This compatibility allows direct hydrogel formation through a simple process of mixing, heating, and cooling. The resulting hydrogel capitalizes on the inherent biological activities of both lipoic acid and guanosine, demonstrating potent antioxidant and antimicrobial properties alongside multi-stimuli responsiveness for diabetic wound management.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"212 ","pages":"Pages 281-299"},"PeriodicalIF":9.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145947150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laser patterning of ECM-derived biomaterials to direct degradation, site-specific resorption, controlled vascularization and functional repair of large nerve defects 激光图图化ecm衍生生物材料对大神经缺损的直接降解、部位特异性吸收、控制血管形成和功能修复。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-03-01 Epub Date: 2026-01-16 DOI: 10.1016/j.actbio.2026.01.031
Zuzana Kočí , Alan J Hibbitts , Simone L Kneafsey , William A Lackington , Giulio Brunetti , Gang Chen , Brenton L. Cavanagh , Conor T Buckley , Simon J Archibald , Fergal J O’Brien
Controlled degradation of extracellular matrix-derived biomaterials in a site-specific and temporal sequence might facilitate early vascularization and improve tissue regeneration. In this study, we developed a tailored laser patterning treatment that successfully addresses this challenge. We show that application of a focused diode-pumped solid-state laser (532 nm) for 30 s duration leads to local heating and reduction of collagen fibril integrity in localized laser-patterned areas of a collagen biomaterial. When implanted in vivo, these thermally degraded regions then become susceptible to further in vivo degradation by inducing site-specific resorption. This allows unimpeded vascular ingrowth and accelerated recovery without prematurely compromising biomaterial structural integrity. Using peripheral nerve injury as an exemplar indication, we show that laser-treated collagen-based nerve guidance conduits (NGCs) have enhanced regenerative potential. Increased in vivo vascularization, in comparison to non laser-treated NGCs, was shown in both a chick chorioallantoic membrane and a rat critical-sized 15 mm sciatic nerve defect model. When nerve repair was assessed, laser-treated NGCs promoted aligned axonal growth and myelin sheath distribution resembling the native nerve, while also restoring nerve action potential to levels of a healthy nerve. This resulted in functional healing and successful nerve recovery as demonstrated by significantly reduced muscle atrophy. This straightforward yet innovative approach offers significant potential for enhancing functional nerve repair when utilizing collagen-based biomaterials but can also be applied to other natural polymer-based biomaterials to tailor degradation and vascularization for a myriad of indications.

Statement of significance

A major challenge associated with implanted biomaterials is the limited control over biomaterial degradation, which can result in failure to adequately repair damaged tissues. In this study, we address this issue through the use of laser patterning which produces localized changes in the structure of extracellular matrix-based biomaterials in the form of depressions and changes in the biochemical composition which then accelerate in vivo biomaterial resorption as the depressions then develop into physical voids. This directs early cell infiltration and eventually vascularization into the biomaterial. At the same time, we show that site-specific resorption does not compromise overall material integrity and allows the implanted biomaterial to maintain its structure so as to facilitate new tissue formation at the injured site.
细胞外基质来源的生物材料在特定部位和时间序列上的受控降解可能促进早期血管形成和改善组织再生。在这项研究中,我们开发了一种定制的激光图案治疗方法,成功地解决了这一挑战。我们发现,聚焦二极管泵浦固体激光器(532 nm)持续30秒的应用会导致胶原蛋白生物材料的局部激光图案区域的局部加热和胶原纤维完整性降低。当植入体内时,这些热降解区域通过诱导部位特异性吸收而变得容易进一步在体内降解。这允许血管不受阻碍地向内生长和加速恢复,而不会过早地损害生物材料的结构完整性。以周围神经损伤为例,我们发现激光治疗的胶原基神经引导导管(NGCs)具有增强的再生潜能。与非激光处理的NGCs相比,在鸡绒毛膜尿囊膜和大鼠15mm坐骨神经缺损模型中均显示出体内血管化的增加。当评估神经修复时,激光治疗的NGCs促进轴突排列生长和髓鞘分布,类似于天然神经,同时也将神经动作电位恢复到健康神经的水平。这导致功能性愈合和成功的神经恢复,肌肉萎缩明显减少。当利用胶原基生物材料时,这种简单而创新的方法为增强功能性神经修复提供了巨大的潜力,但也可以应用于其他天然聚合物基生物材料,以适应各种适应症的降解和血管化。意义声明:植入生物材料的一个主要挑战是对生物材料降解的控制有限,这可能导致无法充分修复受损组织。在这项研究中,我们通过使用激光图案来解决这个问题,激光图案以凹陷的形式在细胞外基质生物材料的结构中产生局部变化,并改变生化成分,然后随着凹陷发展成物理空洞而加速体内生物材料的吸收。这引导了早期细胞的浸润,并最终血管化进入生物材料。同时,我们发现部位特异性吸收不会损害材料的整体完整性,并允许植入的生物材料保持其结构,从而促进损伤部位新组织的形成。
{"title":"Laser patterning of ECM-derived biomaterials to direct degradation, site-specific resorption, controlled vascularization and functional repair of large nerve defects","authors":"Zuzana Kočí ,&nbsp;Alan J Hibbitts ,&nbsp;Simone L Kneafsey ,&nbsp;William A Lackington ,&nbsp;Giulio Brunetti ,&nbsp;Gang Chen ,&nbsp;Brenton L. Cavanagh ,&nbsp;Conor T Buckley ,&nbsp;Simon J Archibald ,&nbsp;Fergal J O’Brien","doi":"10.1016/j.actbio.2026.01.031","DOIUrl":"10.1016/j.actbio.2026.01.031","url":null,"abstract":"<div><div>Controlled degradation of extracellular matrix-derived biomaterials in a site-specific and temporal sequence might facilitate early vascularization and improve tissue regeneration. In this study, we developed a tailored laser patterning treatment that successfully addresses this challenge. We show that application of a focused diode-pumped solid-state laser (532 nm) for 30 s duration leads to local heating and reduction of collagen fibril integrity in localized laser-patterned areas of a collagen biomaterial. When implanted <em>in vivo</em>, these thermally degraded regions then become susceptible to further <em>in vivo</em> degradation by inducing site-specific resorption. This allows unimpeded vascular ingrowth and accelerated recovery without prematurely compromising biomaterial structural integrity. Using peripheral nerve injury as an exemplar indication, we show that laser-treated collagen-based nerve guidance conduits (NGCs) have enhanced regenerative potential. Increased <em>in vivo</em> vascularization, in comparison to non laser-treated NGCs, was shown in both a chick chorioallantoic membrane and a rat critical-sized 15 mm sciatic nerve defect model. When nerve repair was assessed, laser-treated NGCs promoted aligned axonal growth and myelin sheath distribution resembling the native nerve, while also restoring nerve action potential to levels of a healthy nerve. This resulted in functional healing and successful nerve recovery as demonstrated by significantly reduced muscle atrophy. This straightforward yet innovative approach offers significant potential for enhancing functional nerve repair when utilizing collagen-based biomaterials but can also be applied to other natural polymer-based biomaterials to tailor degradation and vascularization for a myriad of indications.</div></div><div><h3>Statement of significance</h3><div>A major challenge associated with implanted biomaterials is the limited control over biomaterial degradation, which can result in failure to adequately repair damaged tissues. In this study, we address this issue through the use of laser patterning which produces localized changes in the structure of extracellular matrix-based biomaterials in the form of depressions and changes in the biochemical composition which then accelerate <em>in vivo</em> biomaterial resorption as the depressions then develop into physical voids. This directs early cell infiltration and eventually vascularization into the biomaterial. At the same time, we show that site-specific resorption does not compromise overall material integrity and allows the implanted biomaterial to maintain its structure so as to facilitate new tissue formation at the injured site.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"212 ","pages":"Pages 187-201"},"PeriodicalIF":9.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145999968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomechanical insights into the development and optimization of small-diameter vascular grafts 小直径血管移植发展和优化的生物力学见解。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-02-01 Epub Date: 2025-04-15 DOI: 10.1016/j.actbio.2025.04.028
Xili Ding , Dongyu Sha , Kaixin Sun , Yubo Fan
Small-diameter vascular grafts (SDVGs; inner diameter ≤6 mm) offer transformative potential for treating cardiovascular diseases, yet their clinical application remains limited due to high rates of complications such as acute thrombosis and intimal hyperplasia (IH), which compromise long-term patency. While advancements in biological and material science have driven progress, the critical role of biomechanical factors—such as hemodynamic forces and mechanical mismatch—in graft failure is often overlooked. This review presents insights from recent clinical trials of SDVG products and summarizes biomechanical contributors to failure, including disturbed flow patterns, mechanical mismatch, and insufficient mechanical strength. We outline essential mechanical performance criteria (e.g., compliance, burst pressure) and evaluation methodologies to assess SDVG performance. Furthermore, we present optimization strategies based on biomechanical principles: (1) graft morphological design optimization to improve hemodynamic stability, (2) structural, material, and fabrication innovations to achieve compliance matching with native arteries, and (3) biomimetic approaches to mimic vascular tissue and promote endothelialization. By systematically addressing these biomechanical challenges, next-generation SDVGs may achieve superior patency, accelerating their clinical translation. This review highlights the necessity of considering biomechanical compatibility in SDVG development, thereby providing initial insights for the clinical translation of SDVG.

Statement of significance

Small-diameter vascular grafts (SDVGs) offer transformative potential for cardiovascular disease treatment but face clinical limitations. While significant progress has been made in biological and material innovations, the critical role of biomechanical factors in graft failure has often been underestimated. This review highlights the importance of biomechanical compatibility in SDVG design and performance, emphasizing the need to address disturbed flow patterns, mechanical mismatch, and inadequate mechanical strength. By proposing optimization strategies based on biomechanical principles, such as graft morphological design, compliance matching, and biomimetic approaches, this work provides a roadmap for developing next-generation SDVGs with improved patency. These advancements have the potential to overcome current limitations, accelerate clinical translation, ultimately benefiting patients worldwide.
小直径血管移植物;内径≤6mm)为治疗心血管疾病提供了变革性的潜力,但由于急性血栓形成和内膜增生(IH)等并发症的高发,其临床应用仍然受到限制,这些并发症会影响长期通畅。虽然生物和材料科学的进步推动了进展,但生物力学因素(如血流动力学力和机械不匹配)在移植物失败中的关键作用经常被忽视。这篇综述介绍了最近SDVG产品临床试验的见解,并总结了导致失败的生物力学因素,包括血流模式紊乱、机械不匹配和机械强度不足。我们概述了基本的机械性能标准(如顺应性、破裂压力)和评估方法,以评估SDVG的性能。此外,我们提出了基于生物力学原理的优化策略:(1)优化移植物形态设计以提高血流动力学稳定性;(2)结构、材料和制造创新以实现与天然动脉的顺应性匹配;(3)模拟血管组织和促进内皮化的仿生方法。通过系统地解决这些生物力学挑战,下一代sdgs可能会获得更好的通畅性,加速其临床转化。这篇综述强调了在SDVG的发展中考虑生物力学相容性的必要性,从而为SDVG的临床翻译提供了初步的见解。意义声明:小直径血管移植(sdvg)为心血管疾病治疗提供了变革性的潜力,但面临临床局限性。虽然在生物和材料创新方面取得了重大进展,但生物力学因素在移植物失败中的关键作用往往被低估。这篇综述强调了生物力学兼容性在SDVG设计和性能中的重要性,强调了解决流动模式紊乱、机械不匹配和机械强度不足的必要性。通过提出基于生物力学原理的优化策略,如移植物形态设计、顺应性匹配和仿生方法,本工作为开发具有更好通畅性的下一代sdgs提供了路线图。这些进步有可能克服目前的限制,加速临床转化,最终使全世界的患者受益。
{"title":"Biomechanical insights into the development and optimization of small-diameter vascular grafts","authors":"Xili Ding ,&nbsp;Dongyu Sha ,&nbsp;Kaixin Sun ,&nbsp;Yubo Fan","doi":"10.1016/j.actbio.2025.04.028","DOIUrl":"10.1016/j.actbio.2025.04.028","url":null,"abstract":"<div><div>Small-diameter vascular grafts (SDVGs; inner diameter ≤6 mm) offer transformative potential for treating cardiovascular diseases, yet their clinical application remains limited due to high rates of complications such as acute thrombosis and intimal hyperplasia (IH), which compromise long-term patency. While advancements in biological and material science have driven progress, the critical role of biomechanical factors—such as hemodynamic forces and mechanical mismatch—in graft failure is often overlooked. This review presents insights from recent clinical trials of SDVG products and summarizes biomechanical contributors to failure, including disturbed flow patterns, mechanical mismatch, and insufficient mechanical strength. We outline essential mechanical performance criteria (e.g., compliance, burst pressure) and evaluation methodologies to assess SDVG performance. Furthermore, we present optimization strategies based on biomechanical principles: (1) graft morphological design optimization to improve hemodynamic stability, (2) structural, material, and fabrication innovations to achieve compliance matching with native arteries, and (3) biomimetic approaches to mimic vascular tissue and promote endothelialization. By systematically addressing these biomechanical challenges, next-generation SDVGs may achieve superior patency, accelerating their clinical translation. This review highlights the necessity of considering biomechanical compatibility in SDVG development, thereby providing initial insights for the clinical translation of SDVG.</div></div><div><h3>Statement of significance</h3><div>Small-diameter vascular grafts (SDVGs) offer transformative potential for cardiovascular disease treatment but face clinical limitations. While significant progress has been made in biological and material innovations, the critical role of biomechanical factors in graft failure has often been underestimated. This review highlights the importance of biomechanical compatibility in SDVG design and performance, emphasizing the need to address disturbed flow patterns, mechanical mismatch, and inadequate mechanical strength. By proposing optimization strategies based on biomechanical principles, such as graft morphological design, compliance matching, and biomimetic approaches, this work provides a roadmap for developing next-generation SDVGs with improved patency. These advancements have the potential to overcome current limitations, accelerate clinical translation, ultimately benefiting patients worldwide.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"211 ","pages":"Pages 104-120"},"PeriodicalIF":9.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144014216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Biomaterialia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1